Springfield, MO

Log in Subscribe

Novartis makes offer to buy German cancer drugmaker

Posted online

Swiss health care company Novartis has made a tender offer to acquire German cancer drugmaker MorphoSys.

Novartis is offering $73 per share, a premium of around 142%.

Novartis also recently announced it's pausing enrollment of new patients in clinical trials for Kisqali, a breast cancer treatment.

Read more from Quartz.


No comments on this story |
Please log in to add your comment
Editors' Pick
Sailing Through the Seasons: The economic wave of lake-based tourism

Table Rock Lake, which has over 800 miles of shoreline and is located primarily within Stone County, is a top lake destination.

Most Read
Update cookies preferences